REGENERX BIOPHARMACEUTICALS INC (14)

Browse by Contract Category

Contracts

Registration Rights Agreement between the Company and various investors dated June 28, 2021 (Filed With SEC on August 6, 2021)
Lock-Up Agreement between Company and various investors dated June 30, 2021 (Filed With SEC on August 6, 2021)
Amendment N. 1 to License Agreement dated February 25, 2019 between the Company and Lees Pharmaceutical (HK) Limited (Filed With SEC on November 14, 2019)
2018 Equity Incentive Plan (Filed With SEC on March 29, 2019)
Securities Purchase Agreement between the Company and various investors dated June 28, 2021 (Filed With SEC on August 6, 2021)
Form of Series A Common Stock Purchase Warrant dated June 30, 2021 (Filed With SEC on August 6, 2021)
Form of Series B Common Stock Purchase Warrant dated June 30, 2021 (Filed With SEC on August 6, 2021)
Form of Convertible Note Purchase Agreement October 2020 (Filed With SEC on November 13, 2020)
Form of Convertible Promissory Note October 2020 (Filed With SEC on November 13, 2020)
Form of Common Stock Warrant October 2020 (Filed With SEC on November 13, 2020)
Amendment No. 1 to RGN-259 License Agreement (PAN ASIA) dated September 17, 2019 between Company and GtreeBNT Co., Ltd (Filed With SEC on November 14, 2019)
Form of Convertible Note Purchase Agreement February 2019 (Filed With SEC on May 15, 2019)
Form of Convertible Promissory Note February 2019 (Filed With SEC on May 15, 2019)
Form of Common Stock Warrant February 2019 (Filed With SEC on May 15, 2019)